COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 191 filers reported holding COHERUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,725,000 | +2.7% | 203,103 | 0.0% | 0.14% | +1.4% |
Q2 2020 | $3,627,000 | +100.3% | 203,103 | +81.9% | 0.14% | +68.3% |
Q1 2020 | $1,811,000 | -19.6% | 111,663 | -10.8% | 0.08% | -3.5% |
Q4 2019 | $2,253,000 | -43.0% | 125,146 | -35.9% | 0.08% | -50.9% |
Q3 2019 | $3,954,000 | -38.6% | 195,146 | -33.0% | 0.17% | -34.2% |
Q2 2019 | $6,440,000 | +49.8% | 291,419 | -7.5% | 0.26% | +50.3% |
Q1 2019 | $4,299,000 | +50.7% | 315,162 | 0.0% | 0.18% | +43.4% |
Q4 2018 | $2,852,000 | +15.4% | 315,162 | +110.4% | 0.12% | +35.6% |
Q3 2018 | $2,472,000 | -26.7% | 149,820 | -37.8% | 0.09% | -29.7% |
Q2 2018 | $3,372,000 | +68.6% | 240,843 | +33.0% | 0.13% | +64.1% |
Q1 2018 | $2,000,000 | +152.5% | 181,023 | +101.1% | 0.08% | +151.6% |
Q4 2017 | $792,000 | -34.1% | 90,000 | 0.0% | 0.03% | -27.9% |
Q3 2017 | $1,202,000 | -7.0% | 90,000 | 0.0% | 0.04% | -10.4% |
Q2 2017 | $1,292,000 | -32.1% | 90,000 | 0.0% | 0.05% | -35.1% |
Q1 2017 | $1,904,000 | -24.9% | 90,000 | 0.0% | 0.07% | -31.5% |
Q4 2016 | $2,534,000 | – | 90,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |